News
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...
Phase 2 of the 137th China Import and Export Fair (Canton Fair), taking place from April 23 to 27, spans an impressive ...
Aker Solutions has delivered high revenue growth and a strong order intake in the first quarter of 2025. The company continues to have a ...
Link11, DOSarrest, and Reblaze have combined their strengths into a single, integrated platform with a new brand identity. The result: ...
Elkem's EBITDA for the first quarter 2025 was NOK 898 million, up from NOK 721 million in the corresponding quarter last year. The ...
Consolidated net profit increased to AED 5.4 billion, reflecting a 129.9 per cent increase year-on-year growth. Excluding the ...
Operating results (EBIT) for the first quarter of 2025 amounted to NOK 9.1 million, compared to NOK 4.9 million in 2024. Operating costs ended at NOK 40.9 million, compared to NOK 38.3 million last ...
The AI as a Service Market is expected to significantly increase from USD 20.26 billion in 2025 to USD 91.20 billion by 2030 ...
The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected ...
OWIT Global (OWIT), the leader in cloud-based insurance-specific microservices architected solutions to digitalize the global ...
Arkieva, a leading provider of supply chain planning software solutions, today announced a significant growth investment from ...
Highlights: HMH reported an adjusted EBITDA of USD 33 million for the quarter, with free cash flow of USD 15 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results